10-QFiling Date: May 5, 2026
TransMedics (TMDX)
10-Q
View SEC Filing
ACC: 0001193125-26-206453
Key Financial Metrics3M Mar'26 · 2026-03-31
Revenue$173.9M
Net Income$7.3M
Total Assets$1.43B
Stockholders' Equity$764.6M
Operating Cash Flow$24.5M
keidHome